Compared with HBV− DLBCL patients, HBV+ DLBCL patients exhibited reduced enrichment of various immune cells in the TME, such as activated CD4+ T cells, Th2 cells, effector memory CD8+ T cells, and eosinophils (Figure 1A). Here, CD8A is linked to diffuse large B-cell lymphoma.